A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
复制标题
血浆中的六微RNA组被确定为肺腺癌诊断的潜在生物标志物
DOI:
10.18632/oncotarget.14311
复制
发表时间:
2017-01-24
期刊:
影响因子:
--
通讯作者:
Shu Y
中科院分区:
文献类型:
--
作者:
Zhou X;Wen W;Shan X;Zhu W;Xu J;Guo R;Cheng W;Wang F;Qi LW;Chen Y;Huang Z;Wang T;Zhu D;Liu P;Shu Y
Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA) patients might serve as biomarkers for LA detection. MiRNA expression profiling was performed using Exiqon panels followed by the verification (30 LA VS. 10 healthy controls (HCs)) with quantitative reverse transcription polymerase chain reaction (qRT-PCR) in the screening phase. Identified miRNAs were confirmed through training (42 LA VS. 32 HCs) and testing stages (66 LA VS. 62 HCs) by using qRT-PCR based absolute quantification methods. A total of six up-regulated plasma miRNAs (miR-19b-3p, miR-21-5p, miR-221-3p, miR-409-3p, miR-425-5p and miR-584-5p) were identified. The six-miRNA panel could discriminate LA patients from HCs with areas under the receiver operating characteristic curve of 0.72, 0.74 and 0.84 for the training, testing and the external validation stage (33 LA VS. 30 HCs), respectively. All the miRNAs identified except miR-584-5p were significantly up-regulated in LA tissues. MiR-19-3p, miR-21-5p, miR-409-3p and miR-425-5p showed high expression in arterial plasma with borderline significance. Additionally, miR-19-3p, miR-21-5p and miR-221-3p were significantly up-regulated in exosomes extracted from LA peripheral plasma samples. In conclusion, we identified a six-miRNA panel in peripheral plasma which might give assistance to the detection of LA at least for Asian population to a certain extent.